The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group

Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and sy...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23803
Acceso en línea:
https://doi.org/10.1007/s12281-019-00365-3
https://repository.urosario.edu.co/handle/10336/23803
Palabra clave:
Itraconazole
Acquired immune deficiency syndrome
Brazil
Clinical feature
Consensus development
Diagnostic test
Disease severity
Disease surveillance
Health care organization
Health care planning
Health program
High risk patient
Histoplasmosis
Human
Human immunodeficiency virus infected patient
Human immunodeficiency virus infection
In vitro study
International cooperation
Medical technology
Patient care
Practice guideline
Review
Symptom
Western hemisphere
World health organization
Aids
Diagnosis
Guidelines
Histoplasma
Histoplasmosis
Treatment
Rights
License
Abierto (Texto Completo)
Description
Summary:Purpose of Review: The aim of this report is to summarize the conclusions of the II Regional Meeting on Histoplasmosis in the Americas held in Manaus, Brazil, on March 22–24, 2019. Recent Findings: Persons living with advanced HIV are at high risk for developing histoplasmosis. Clinical signs and symptoms of this disease are often non-specific, making it difficult to establish a diagnosis. Although with the recent technological advances, in vitro diagnostics and medicines for histoplasmosis are often not available in many regions around the world. In addition, histoplasmosis is often not included in HIV care and treatment programs, resulting in inadequate health system planning and missed opportunities to save lives. Summary: The II Regional Meeting on Histoplasmosis in the Americas gathered a multidisciplinary audience. Developed recommendations to be included in the WHO guidelines for diagnosis and treatment of histoplasmosis in advanced HIV were the product of this meeting, and guidelines are aimed to be published in early 2020. © 2019, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.